|
Clinical Trials and Observations
Citations 411-420 of 2742 total displayed.
|
Past content
(since May 1998):
|
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)
- John A. Thompson, Richard I. Fisher, Michael LeBlanc, Stephen J. Forman, Oliver W. Press, Joseph M. Unger, Auayporn P. Nademanee, Patrick J. Stiff, Stephen H. Petersdorf, and Alexander Fefer
Blood 2008; 111: 4048-4054.
[Abstract]
[Full text]
[PDF]
CYP4F2 genetic variant alters required warfarin dose
- Michael D. Caldwell, Tarif Awad, Julie A. Johnson, Brian F. Gage, Mat Falkowski, Paul Gardina, Jason Hubbard, Yaron Turpaz, Taimour Y. Langaee, Charles Eby, Cristi R. King, Amy Brower, John R. Schmelzer, Ingrid Glurich, Humberto J. Vidaillet, Steven H. Yale, Kai Qi Zhang, Richard L. Berg, and James K. Burmester
Blood 2008; 111: 4106-4112.
[Abstract]
[Full text]
[PDF]
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
- Ophira Salomon, David M. Steinberg, Nira Koren-Morag, David Tanne, and Uri Seligsohn
Blood 2008; 111: 4113-4117.
[Abstract]
[Full text]
[PDF]
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients
- Barbara Cassani, Massimiliano Mirolo, Federica Cattaneo, Ulrike Benninghoff, Michael Hershfield, Filippo Carlucci, Antonella Tabucchi, Claudio Bordignon, Maria Grazia Roncarolo, and Alessandro Aiuti
Blood 2008; 111: 4209-4219.
[Abstract]
[Full text]
[PDF]
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis
- Brian V. Balgobind, Pieter Van Vlierberghe, Ans M. W. van den Ouweland, H. Berna Beverloo, Joan N. R. Terlouw-Kromosoeto, Elisabeth R. van Wering, Dirk Reinhardt, Martin Horstmann, Gertjan J. L. Kaspers, Rob Pieters, C. Michel Zwaan, Marry M. Van den Heuvel-Eibrink, and Jules P. P. Meijerink
Blood 2008; 111: 4322-4328.
[Abstract]
[Full text]
[PDF]
High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
- Sanne Lugthart, Ellen van Drunen, Yvette van Norden, Antoinette van Hoven, Claudia A. J. Erpelinck, Peter J. M. Valk, H. Berna Beverloo, Bob Löwenberg, and Ruud Delwel
Blood 2008; 111: 4329-4337.
[Abstract]
[Full text]
[PDF]
A functional TNFRSF5 gene variant is associated with risk of lymphoma
- Christine F. Skibola, Alexandra Nieters, Paige M. Bracci, John D. Curry, Luz Agana, Danica R. Skibola, Alan Hubbard, Nikolaus Becker, Martyn T. Smith, and Elizabeth A. Holly
Blood 2008; 111: 4348-4354.
[Abstract]
[Full text]
[PDF]
Screening for hemochromatosis by measuring ferritin levels: a more effective approach
- Jill Waalen, Vincent J. Felitti, Terri Gelbart, and Ernest Beutler
Blood 2008; 111: 3373-3376.
[Abstract]
[Full text]
[PDF]
Interleukin-2, interleukin-12, and interferon- levels and risk of young adult Hodgkin lymphoma
- Wendy Cozen, Parkash S. Gill, Muhammad T. Salam, Alexandra Nieters, Rizwan Masood, Myles G. Cockburn, W. James Gauderman, Otoniel Martínez-Maza, Bharat N. Nathwani, Malcolm C. Pike, David J. Van Den Berg, Ann S. Hamilton, Dennis M. Deapen, and Thomas M. Mack
Blood 2008; 111: 3377-3382.
[Abstract]
[Full text]
[PDF]
A dynamic prognostic model to predict survival in post–polycythemia vera myelofibrosis
- Francesco Passamonti, Elisa Rumi, Marianna Caramella, Chiara Elena, Luca Arcaini, Emanuela Boveri, Cecilia Del Curto, Daniela Pietra, Laura Vanelli, Paolo Bernasconi, Cristiana Pascutto, Mario Cazzola, Enrica Morra, and Mario Lazzarino
Blood 2008; 111: 3383-3387.
[Abstract]
[Full text]
[PDF]
|
|
